Key statistics
As of last trade Ionis Pharmaceuticals Inc (ISI:DUS) traded at 32.17, 2.06% above its 52-week low of 31.52, set on Nov 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 32.18 |
---|---|
High | 32.18 |
Low | 32.17 |
Bid | 32.25 |
Offer | 32.73 |
Previous close | 32.80 |
Average volume | 2.22 |
---|---|
Shares outstanding | 157.90m |
Free float | 156.69m |
P/E (TTM) | -- |
Market cap | 5.36bn USD |
EPS (TTM) | -2.45 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 08:30 GMT.
More ▼
Press releases
- Ionis to present at upcoming investor conferences
- Ionis Announces Pivotal Phase 3 Trial Design for ION582 in Angelman Syndrome
- Ionis reports third quarter 2024 financial results
- Ionis announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE
- Ionis to hold third quarter 2024 financial results webcast
- WAINZUA (eplontersen) recommended for approval in the EU by CHMP for the treatment of adults with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis
- New positive donidalorsen data to be presented at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
- Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease
- Ionis announces pricing of $500.3 million public offering
- Ionis announces proposed public offering of common stock
More ▼